» Articles » PMID: 23001988

Targeting Wnt Pathways in Disease

Overview
Date 2012 Sep 25
PMID 23001988
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Wnt-mediated signal transduction pathways have long been recognized for their roles in regulating embryonic development, and have more recently been linked to cancer, neurologic diseases, inflammatory diseases, and disorders of endocrine function and bone metabolism in adults. Although therapies targeting Wnt signaling are attractive in theory, in practice it has been difficult to obtain specific therapeutics because many components of Wnt signaling pathways are also involved in other cellular processes, thereby reducing the specificity of candidate therapeutics. New technologies, and advances in understanding the mechanisms of Wnt signaling, have improved our understanding of the nuances of Wnt signaling and are leading to promising new strategies to target Wnt signaling pathways.

Citing Articles

CSNK1E is involved in TGF-β1 induced epithelial mesenchymal transformationas and related to melanoma immune heterogeneity.

Hong W, Wang X, Huang X, Chen P, Liu Y, Zheng Z Front Pharmacol. 2025; 15():1501849.

PMID: 39872053 PMC: 11771321. DOI: 10.3389/fphar.2024.1501849.


Unraveling the Role of Wnt Signaling Pathway in the Pathogenesis of Autism Spectrum Disorder (ASD): A Systematic Review.

Bou Najm D, Alame S, Takash Chamoun W Mol Neurobiol. 2024; 62(4):4971-4992.

PMID: 39489840 DOI: 10.1007/s12035-024-04558-x.


A guide to selecting high-performing antibodies for Secreted frizzled-related protein 1 (sFRP-1) for use in Western Blot and immunoprecipitation.

Ayoubi R, Southern K, Laflamme C F1000Res. 2024; 12:291.

PMID: 39319244 PMC: 11420615. DOI: 10.12688/f1000research.130991.2.


Wnt Signaling in Atherosclerosis: Mechanisms to Therapeutic Implications.

Afroz R, Goodwin J Biomedicines. 2024; 12(2).

PMID: 38397878 PMC: 10886882. DOI: 10.3390/biomedicines12020276.


The regulatory role and clinical application prospects of circRNA in the occurrence and development of CNS tumors.

Zhang B, Zhang H, Wang Z, Cao H, Zhang N, Dai Z CNS Neurosci Ther. 2023; 30(4):e14500.

PMID: 37953502 PMC: 11017455. DOI: 10.1111/cns.14500.


References
1.
Gonsalves F, Klein K, Carson B, Katz S, Ekas L, Evans S . An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc Natl Acad Sci U S A. 2011; 108(15):5954-63. PMC: 3076864. DOI: 10.1073/pnas.1017496108. View

2.
Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez R, Wang Y . Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science. 2010; 329(5993):849-53. PMC: 3732486. DOI: 10.1126/science.1188510. View

3.
Lengerke C, Schmitt S, Bowman T, Jang I, Maouche-Chretien L, McKinney-Freeman S . BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell. 2008; 2(1):72-82. DOI: 10.1016/j.stem.2007.10.022. View

4.
Mikami I, You L, He B, Xu Z, Batra S, Lee A . Efficacy of Wnt-1 monoclonal antibody in sarcoma cells. BMC Cancer. 2005; 5:53. PMC: 1164405. DOI: 10.1186/1471-2407-5-53. View

5.
Kang D, Soriano S, Xia X, Eberhart C, De Strooper B, Zheng H . Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell. 2002; 110(6):751-62. DOI: 10.1016/s0092-8674(02)00970-4. View